-
Nov 21, 2024 | 
medscape.com | Kathy D. Miller |Stephanie Graff
Authors and Disclosures Kathy D. Miller, MD Ballvé Lantero Professor, Department of Medicine, Division of Hematology and Oncology; Associate Director for Clinical Research, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IndianaDisclosure: Kathy D.
-
Oct 22, 2024 | 
medscape.com | Kathy D. Miller |Nancy Lin
Authors and Disclosures Kathy D. Miller, MD Ballvé Lantero Professor, Department of Medicine, Division of Hematology and Oncology; Associate Director for Clinical Research, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IndianaDisclosure: Kathy D.
-
Sep 19, 2024 | 
medscape.com | Kathy D. Miller |Heather A. Parsons
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Kathy D. Miller, MD: Hi, everyone. I'm Dr Kathy Miller. Welcome to the Medscape InDiscussion podcast series on breast cancer and HER2. Today, we are going to tackle the management of patients with HER2+ oligometastatic disease.
-
Aug 20, 2024 | 
medscape.com | Kathy D. Miller |Sunil S. Badve
closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Kathy D. Miller, MD: Hi, everyone. I'm Dr Kathy Miller. Welcome to the Medscape InDiscussion podcast series on breast cancer and HER2.
-
Aug 20, 2024 | 
medscape.com | Kathy D. Miller |Sara M. Tolaney
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Kathy D. Miller, MD: Hi. I'm Dr Kathy Miller. Welcome to the Medscape InDiscussion podcast on breast cancer and HER2. Today we'll talk about whether we're ready to begin thinking about overtreatment of patients with HER2-positive disease. Now, this seems odd at first pass. This is an aggressive form of breast cancer.
-
Jun 3, 2024 | 
medicine.iu.edu | Bryan Schneider |Kathy D. Miller
INDIANAPOLIS — Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center and the IU School of Medicine have discovered that Black patients with breast cancer who are treated with a chemotherapy called docetaxel experience less of a harmful side effect called peripheral neuropathy. Their findings represent an important shift in knowledge about a patient population who’ve historically been underrepresented in breast cancer research.
-
Mar 27, 2024 | 
medscape.com | Kathy D. Miller
closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. My Alerts You have already selected for My Alerts Add Other Topics Click the topic below to receive emails when new articles are available. Add You've successfully added to your alerts. You will receive email when new content is published. Manage Email Alerts Manage Email Alerts
-
Mar 14, 2024 | 
medscape.com | Kathy D. Miller
closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. My Alerts You have already selected for My Alerts Add Other Topics Click the topic below to receive emails when new articles are available. Add You've successfully added to your alerts. You will receive email when new content is published. Manage Email Alerts Manage Email Alerts
-
Mar 4, 2024 | 
medscape.com | Kathy D. Miller
closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. My Alerts You have already selected for My Alerts Add Other Topics Click the topic below to receive emails when new articles are available. Add You've successfully added to your alerts. You will receive email when new content is published. Manage Email Alerts Manage Email Alerts
-
Feb 27, 2024 | 
medscape.com | Kathy D. Miller
closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. My Alerts You have already selected for My Alerts Add Other Topics Click the topic below to receive emails when new articles are available. Add You've successfully added to your alerts. You will receive email when new content is published. Manage Email Alerts Manage Email Alerts
